FGF21 and chronic kidney disease: The kidney exhibits resistance to the effects of FGF21 early on in CKD; however, further studies in preclinical models of CKD are needed to determine the mechanism by which FGF21 seems to lose its protective actions on kidney function in the early stages of CKD.